Skip to content

Efficacy of topical product of Rhus coriaria on head lice

Efficacy of topical product of Rhus coriaria on head lice

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180712040446N1
Enrollment
60
Registered
2018-07-22
Start date
2018-02-19
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediculosis. Head louse infestation

Interventions

The study will be conducted as a before and after clinical trial . In intervention group, for each patient, 60 cc of Rhus coriaria product, sprayed for three continuous days, 20 cc daily with a plast

Sponsors

Vice Chancellor for research,Traditional Medicine School,Shahid Beheshti University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to No maximum

Inclusion criteria

Inclusion criteria: Take at least two continuous period of permethrin, according to the correct instruction Having at least grade one (5-9 nit or live lice) according to severity of the contamination

Exclusion criteria

Exclusion criteria: Sensitivity to product Head skin ulcers Secondary skin infection including Impetigo Chronic skin disease such as Psoriasis Immunodeficiency Pregnancy Participation in any clinical trial within the past 4 weeks Use less than twice in every three consecutive days The concomitant use of another anti-lice drugs

Design outcomes

Primary

MeasureTime frame
Pediculosis severity of contamination. Timepoint: At the beginning of the intervention, 4, 10, and 14 days after the start of the Rhus coriaria product. Method of measurement: Mature insect count and lice egg.

Secondary

MeasureTime frame
Pruritus rate. Timepoint: At the beginning of the intervention, 4, 10, and 14 days after the start of the Rhus coriaria product. Method of measurement: Ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefe Sharif

School of Traditional Medicine, Shahid Beheshti University of Medical Sciences

atf.sharif@gmail.com+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026